analyst
OTC · BMYMP
Bristol-Myers Squibb Company PFD CONV 2
Healthcare · Drug Manufacturers - General
$400.00
Down-$540.22 (-57.46%)
Updated Sep 16, 2026, 10:24 AM
SID Score
6.8/10
Composite research score
Smart Money
46/100
Neutral
- Market cap
- 1.82T
- P/E ratio
- 17.28
- Dividend yield
- 0.50%
- 52-week range
- — – —
- Volume
- 13
- Avg. volume
- 5
Price performance
BMYMP price history
1M range · 0 trading sessions · Daily adjusted prices
BMYMP does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest BMYMP news
The latest Smart Investors Daily articles mentioning BMYMP.
Stock researchCompany · Overview
BMYMP research
Overview
Company profile and research snapshot.
Company profile
BRISTOL-MYERS SQUIBB $2PR
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- —
- Implied upside
- —
- Analysts
- 17
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 10, 2026 | HSBC | Hold | — |
| Aug 5, 2026 | Argus Research | Buy | — |
| Aug 3, 2026 | Citigroup | Neutral | — |
| Jul 31, 2026 | Guggenheim | Buy | — |
| Jul 31, 2026 | Truist Securities | Buy | — |
News briefing
Data unavailable
Market data is busy. Please try again shortly.
AI research layers
Interpretive context generated from the platform’s current data sources.
Data unavailable
Market data is busy. Please try again shortly.